RCRafał Czajkowski

Rafał Czajkowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rafał Czajkowski has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Dorota Olszewska-Słonina

    Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland

    2 shared publications
  • Alina Woźniak

    Department of Medical Biology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

    1 shared publication
  • Barbara Zegarska

    Department of Cosmetology and Esthetic Dermatology, Ludwik Rydygier Medical College in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland. Head of the Department: Prof. Barbara Zegarska MD, PhD

    1 shared publication
  • Bogna Kowaliszyn

    Department of Genetics and General Animal Breeding, Faculty of Animal Breeding and Biology, University of Technology and Life Sciences Bydgoszcz, Poland

    1 shared publication
  • Czanita Cieścińska

    Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Ludwik Rydygier Medical College in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland. Head of the Department: Rafał Czajkowski MD, PhD, DSc

    1 shared publication
  • Dariusz Musiałkiewicz

    Department of Medical Biology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

    1 shared publication

Latest Publications

  • Open Access

    Letter to the Editor Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review

    by Krystyna Romańska-Gocka, Czanita Cieścińska, Barbara Zegarska, Robert A. Schwartz, Jakub Cieściński, Dorota Olszewska-Słonina, Rafał Czajkowski


  • Open Access

    Current aspects of vitiligo genetics

    by Rafał Czajkowski, Kaja Męcińska-Jundziłł

    Vitiligo is a common acquired depigmentation disorder of the skin manifested by the presence of white macules. The disease occurs at a frequency of approximately 1–4% of the world population. Currently, the most popular theory of vitiligo development is a multifactorial hypothesis according...


  • Open Access

    Sweet’s syndrome with idiopathic thrombocythemia

    by Sebastian Kaszewski, Rafał Czajkowski, Franciszka Protas-Drozd, Waldemar Placek, Sebastian Jakubowski

    Diagnosis of paraneoplastic skin syndromes associating neoplastic processes is assumed as the crucial aspect of dermatological practice. Knowledge of clinical findings of dermatoses suggesting coincidence of malignant proliferative processes facilitates diagnostic and therapeutic procedures. We...


  • BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment

    by Rafal Czajkowski

    Background  Cultured pigment cells are increasingly being used in the treatment of stable vitiligo. The melanocyte growth media contain synthetic and human recombinant mitogenic factors. High concentration of growth factors, increased melanin biosynthesis, and the rapid cell cycle progression may lead to the genetic material damage and the initiation of melanocyte malignant transformation in cell culture conditions. Mutations of genes of the RAS/RAF/MEK/ERK signaling pathway and CDKN2A gene are often found in the early stages of melanoma development. 12‐O‐Tetradecanoyl‐phorbol‐13‐acetate (TPA)/phorbol 12‐myristate 13‐acetate (PMA) is considered to be an oncogenic factor, but there is no evidence that it is responsible for melanomagenesis initiation. The goal of this research was to assess the risk of the development of mutations in selected genes of the RAS/RAF/MEK/ERK signaling pathway and CDKN2A gene during the culturing of pigment cells in various growth media.Methods  Three‐hundred melanocyte cultures were established in 10 various growth media. The population doubling time of cultured cells was calculated for all the tested growth media. Cytogenetic analysis was carried out on the HRAS (exon 1 and 2), KRAS (exon 1 and 2), NRAS (exon 1 and 2), BRAF (exon 11 and 15), and CDKN2A (exon 1) genes.Results  Our study revealed that TPA and high concentrations of other growth factors intensify the proliferation of pigment cells, without the risk of damage to the analyzed genes.Conclusions  It is necessary to carry out further similar studies on other signaling pathways to confirm cultured melanocytes transplantation safety.


  • Open Access

    The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation

    by Dorota M. Olszewska-Słonina, Dariusz Mątewski, Rafał Czajkowski, Krzysztof J. Olszewski, Alina Woźniak, Grażyna Odrowąż-Sypniewska, Kinga Lis, Dariusz Musiałkiewicz, Bogna Kowaliszyn

    The aim of this study was to evaluate the concentration of malondialdehyde (MDA) in erythrocytes and in blood plasma and the activity of blood paraoxonase (PON1) of patients with osteoarthrosis (OA) submitted to endoprosthesis implantation for evaluating oxidative stress. Study was conducted on 55 patients with OA and on 54 total movement-efficient volunteers. The material for the study was venous blood plasma, serum and erythrocytes. Increased concentration of MDAe before surgery was observed in the group of men and in patients with a degenerative process affecting hip joints. After an implantation of endoprosthesis, MDAe decreased to the level observed in the control groups. In the study group MDA concentration in plasma was slightly lower before surgery, and after an operation it reached the value of the parameter of the reference groups. Regardless of sex or age, paraoxonase activity was almost twice as high in almost all subgroups as in the reference group. A positive correlation between PON 1 activity and MDAe concentration was demonstrated both before and after surgery in the group of men. The increase of PON1 activity in patients’ serum in relation to the control groups indicates a probable pathogenic role of the increased formation of reactive oxygen species in the course of OA and may suggest acute inflammation of the synovial joint. The high level of PON 1 activity after endoprosthesis implantation indicates that surgical treatment may additionally stimulate ROS generation. MDAe concentration indicate more intensive process of lipid peroxidation in the elderly.